Clinical Journal of the American Society of Nephrology

Renal Outcomes of Triglyceride-Targeting Lipid-Lowering Therapies versus Statins in Patients with CKD

By Mohammad Abdullah Al Zubair Naim, Fridtjof Thomas, Elani Streja, Csaba Pal Kovesdy

Study in peopleInterventions

The paper

Mohammad Abdullah Al Zubair Naim, Fridtjof Thomas, Elani Streja, Csaba Pal Kovesdy

University of Tennessee Health Science Center

Clinical Journal of the American Society of Nephrology, 11 Aug 2026

doi.org/10.2215/cjn.0000001188 PubMed 42579537

Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk